Treatment of hepatocellular carcinoma:TACE or HAIC?

VernacularTitle:肝癌TACE还是HAIC?
Author: Nan DU ¹ ; Ying WANG ; Wentao LI
Author Information

1. 200032 上海复旦大学附属肿瘤医院介入治疗科;复旦大学上海医学院肿瘤学系
Keywords: hepatocellular carcinoma; transcatheter arterial chemoembolization; hepatic artery infusion chemotherapy; molecular targeted drug therapy
From: Journal of Interventional Radiology 2024;33(12):1269-1273
CountryChina
Language:Chinese
Abstract: At present,transcatheter arterial chemoembolization(TACE)is a common treatment for advanced unresectable hepatocellular carcinoma(HCC).In recent years,hepatic artery infusion chemotherapy(HAIC)with oxaliplatin plus fluorouracil and leucovorin(FOLFOX)regimen has been used in the treatment of advanced HCC in China.HAIC in combination with molecular targeted drugs and/or immune checkpoint inhibitors has yielded encouraging results.This paper aims to describe the theoretical basis,development history and research progress of TACE and HAIC,to analyze and compare the efficacy and adverse events of TACE and HAIC,so as to provide a reference for the choice of treatment timing and therapeutic regimen for patients with advanced HCC.